Biphasic Synovial Sarcoma of the Hypopharynx in a Six-Year-Old Child Diagnosed via SS18 Immunohistochemistry Without Molecular Confirmation in a Resource-Limited Setting: A Case Report

Imagine the human body as a bustling city, where every neighborhood has its own specific job. In the soft, squishy tissues that cushion our muscles and organs, there's a rare and mischievous troublemaker called a synovial sarcoma. Think of it as a sneaky construction crew that usually builds its chaotic skyscrapers in the limbs (arms and legs) of young adults. However, this crew is notorious for occasionally setting up shop in the wrong place: the head and neck. When they do, they are like a hidden sinkhole under a smooth sidewalk; they grow under the surface skin (mucosa) without breaking it, making them incredibly hard to spot until they block the road (the airway).

To catch these troublemakers, doctors usually need a special "genetic ID card" to prove who they are. This ID card is a specific swap of genetic material between two chromosomes, known as a translocation. In a perfect world, doctors would use high-tech molecular machines (like FISH or PCR) to read this ID card. But in many parts of the world, these machines are as rare as unicorns. Instead, doctors have to rely on a "surrogate detective"—a special stain called SS18 immunohistochemistry. If the tumor lights up with this stain, it's a very strong clue that the genetic ID card is there, even if we can't read the card itself. This story is about a team of doctors in Uzbekistan who had to solve a medical mystery using only their detective skills and this special stain, because the high-tech machines were out of reach.

---

The Case of the Six-Year-Old's Hidden Blockage

Meet our protagonist: a six-year-old girl from Tashkent, Uzbekistan. For a whole year, she had been slowly losing her breath, her voice sounding strange and nasal. At first, local doctors thought she just had a simple sore throat or a harmless polyp. They took a tiny sample (a biopsy) from the surface, but because the tumor was hiding deep under the skin like a mole under a blanket, the sample only showed "scraped-up" tissue. It was a dead end.

By the time she arrived at the AKFA Medline University Hospital, the situation was critical. A massive, smooth, pinkish tumor had grown to the size of a small orange (2.9 × 2.5 × 3.8 cm) and was squeezing 90% of her airway shut. It was a race against time. The medical team had to perform an emergency tracheostomy (making a hole in her neck to let her breathe) and then cut the tumor out through an open surgery.

The Diagnostic Puzzle
When the tumor was sent to the lab, the first look under the microscope was confusing. The cells looked like a chaotic mess of "blue" round cells, and the doctors initially thought it was a different, very aggressive cancer called a "Grade 3 embryonal sarcoma." This is like looking at a shadow and guessing it's a bear, when it might actually be a wolf.

But the team didn't stop there. They used a powerful, automated detective tool: a special stain for SS18.

• The Big Clue: The tumor cells lit up brightly and everywhere with the SS18 stain. This is the "surrogate detective" mentioned earlier. It is so good at spotting synovial sarcoma that it acts almost exactly like the genetic ID card.
• The Confirmation: They also checked for other markers. The tumor had a mix of two types of cells (spindle cells and some skin-like cells), which is the signature of a "biphasic" synovial sarcoma. They ran a long list of tests to rule out other suspects (like nerve tumors or muscle cancers), and every single one came back negative.

Because they couldn't use the high-tech genetic machines (due to resource limits), they relied on this perfect storm of evidence: the classic look of the cells under the microscope, the bright SS18 stain, and the fact that it wasn't any of the other common cancers. They reclassified the tumor: it wasn't a Grade 3 embryonal sarcoma; it was a Grade 2 Biphasic Synovial Sarcoma. This was a huge relief because "Grade 2" is less aggressive than "Grade 3."

The Treatment and Outcome
Usually, when a cancer is this rare and aggressive, doctors might immediately blast the patient with chemotherapy or radiation. However, this team looked at the whole picture:

1. The tumor was completely removed.
2. It was only Grade 2 (not the worst kind).
3. There was no dead tissue (necrosis) inside the tumor, which is a bad sign.
4. A follow-up PET-CT scan (a special camera that sees if cancer is hungry for sugar) showed no cancer in the lymph nodes or anywhere else in the body. The swollen nodes seen earlier were just the body reacting to the infection, not cancer.

Because of these good signs, the doctors decided to skip the heavy chemotherapy and radiation for now. Instead, they chose active surveillance. This means watching the patient very closely, like a hawk, every three months, ready to act if anything changes.

The Result
Fast forward 22 months (as of June 2026). The little girl is doing amazingly well. She has had her tracheostomy tube removed and is breathing and swallowing normally. She is running, playing, and has no signs of the cancer coming back.

Why This Matters
This paper tells us three important things:

1. Age is just a number: This is one of the youngest cases ever recorded (a six-year-old) of this specific cancer in the throat. It proves that this "adult" disease can strike very young children.
2. Don't just scratch the surface: If a child has a growing lump in the throat that doesn't go away, a tiny surface biopsy isn't enough. You need to dig deep to get the real answer, or the tumor will keep growing.
3. Detective work works: Even without the most expensive genetic machines, a smart combination of microscope looks and the SS18 stain can give a definitive diagnosis. This is a lifeline for doctors in places where high-tech tools are hard to find.

The doctors warn that while the news is great right now, synovial sarcoma is known for being patient; it can hide and come back many years later. So, this girl will need to keep coming back for check-ups for at least the next ten years. But for now, she is a victory for careful detective work and brave surgery.